ArticleItalian journal of pediatrics2026
Construction of a forest plot prediction model based on Lasso regression for Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in children.
Article in Italian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo identify risk factors for the progression of Epstein-Barr virus(EBV) infection to Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) and guide clinical intervention by analyzing the clinical data and laboratory examination between infectious mononucleosis and EBV-HLH infection using a forest plot prediction model.
methodsClinical data and laboratory tests of children with “Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis” who were hospitalized in Children’s Hospital of Soochow University from January 2019 to December 2024 were collected. A total of 1358 children of infectious mononucleosis associated with EBV (IM group) and 86 children of hemophagocytic lymphohistiocytosis associated with EBV (EBV-HLH group) were included. The differences between the groups were retrospectively analyzed and regression analysis was performed. The proximity matching method was selected for 1:4 matching between the EBV-HLH group and the IM group. The forest plot prediction model was established based on Lasso regression to analyze the clinical differences between the IM group and the EBV-HLH group.
resultsLasso regression model screening identified hemoglobin (HB), ferritin (FER), fibrinogen (FIB) and CD3 + CD4 + as hexhibiting good predictive value for EBV-HLH, with areas under the receiver operating characteristic (ROC) curve of 0.904, 0.973, 0.866 and 0.783, and specificities of 0.799, 0.965, 0.802 and 0.892, respectively. The prediction model constructed using HB, FER, FIB, and CD3 + CD4 + showed excellent predictive accuracy. With an optimal cut-off value of F = 56.95, the model achieved a sensitivity of 95.30% and a specificity of 99.70%.
conclusionsThe early diagnosis of EBV-HLH lacks specific indicators. In this study, a predictive model for EBV-HLH was established using LASSO regression, incorporating four key parameters (HB, FER, FIB, and CD3 + CD4 + T-cell subsets). This model may serve as a screening tool for the early diagnosis of EBV-HLH and provide a diagnostic basis for clinical practice. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.